Mediclin AG (MED.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap175.75M
Enterprise Value494.4M
P/E Ratio9.21
PEG Ratio-0.72
Price/Sales Ratio0.34
Price/Book Ratio1.02
Enterprise/Revenue0.73
Enterprise/EBITDA13.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.12

Income Statement

Revenue784.49M
Revenue/Share16.57
Gross Profit113.81M
EBITDA98.66M
Net Income25.49M
Diluted EPS0.54

Balance Sheet

Total Cash77.39M
Total Cash/Share1.63
Total Debt382.37M
Total Debt/Equity1.47
Current Ratio1.73
Book Value Per Share5.48

Price History

52-Week Change87.92
52-Week High5.7
52-Week Low2.9
Moving Average 50 Days4.66
Moving Average 200 Days3.95

Statistics

Average Volume6,745
Shares Outstanding47.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.71
Payout Ratio0.07
Last Split FactorN/A
Last Split DateN/A
AD